Drugs Made In Stock Probability of Future Stock Price Finishing Over 10.00
| DMII Stock | 10.00 0.02 0.20% |
Drugs Made Target Price Odds to finish over 10.00
The tendency of Drugs Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.00 | 90 days | 10.00 | about 6.57 |
Based on a normal probability distribution, the odds of Drugs Made to move above the current price in 90 days from now is about 6.57 (This Drugs Made In probability density function shows the probability of Drugs Stock to fall within a particular range of prices over 90 days) .
Drugs Made Price Density |
| Price |
Predictive Modules for Drugs Made
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Drugs Made In. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Drugs Made Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Drugs Made is not an exception. The market had few large corrections towards the Drugs Made's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Drugs Made In, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Drugs Made within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.16 |
Drugs Made Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Drugs Made for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Drugs Made In can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Drugs Made In has a very weak financial position based on the latest SEC disclosures | |
| About 18.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: NVIDIA Just Made a Bigger Push Into AI Drug Discovery - 247 Wall St. |
Drugs Made Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Drugs Stock often depends not only on the future outlook of the current and potential Drugs Made's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Drugs Made's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Percent Float | 0.0014 | |
| Shares Short Prior Month | 103.6 K | |
| Shares Float | 58.7 M | |
| Short Percent | 0.0014 |
Drugs Made Technical Analysis
Drugs Made's future price can be derived by breaking down and analyzing its technical indicators over time. Drugs Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Drugs Made In. In general, you should focus on analyzing Drugs Stock price patterns and their correlations with different microeconomic environments and drivers.
Drugs Made Predictive Forecast Models
Drugs Made's time-series forecasting models is one of many Drugs Made's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Drugs Made's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Drugs Made In
Checking the ongoing alerts about Drugs Made for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Drugs Made In help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Drugs Made In has a very weak financial position based on the latest SEC disclosures | |
| About 18.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: NVIDIA Just Made a Bigger Push Into AI Drug Discovery - 247 Wall St. |
Check out Drugs Made Analysis, Drugs Made Valuation, Drugs Made Correlation, Drugs Made Hype Analysis, Drugs Made Volatility, Drugs Made Price History as well as Drugs Made Performance. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is there potential for Diversified Capital Markets market expansion? Will Drugs introduce new products? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Drugs Made In's market price often diverges from its book value, the accounting figure shown on Drugs's balance sheet. Smart investors calculate Drugs Made's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Drugs Made's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.